Fresenius Kabi Ipsum Srl, based in Sweden, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CEFTRIAXONE SODIUM STERILE, with a corresponding US DMF Number 19627.
Remarkably, this DMF maintains an Active status since its submission on July 21, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 28, 2014, and payment made on April 18, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II